Cyp3a Inducers + Belumosudil Interaction
Moderateinteraction on record
Description
Strong CYP3A inducers decrease belumosudil exposure and may reduce efficacy. Increase REZUROCK dosage to 200 mg twice daily when used concomitantly.
Mechanism
Belumosudil is a CYP3A substrate
Source: NLP:belumosudil